Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) remains a major global health challenge, with current treatments often limited by drug resistance and severe side effects. Natural products, particularly functional beverages, have emerged as promising alternative therapeutic agents. This study investigated the anticancer efficacy of a functional beverage by combining white tea vinegar (WTV) and Triphala extract (TE) against Caco-2 and LoVo cells. In vitro assays demonstrated that the treatments, particularly the combination of WTV and TE (WTE), synergistically induced severe intracellular ROS accumulation and subsequent DNA fragmentation. Furthermore, WTE profoundly triggered the intrinsic apoptotic cascade, evidenced by mitochondrial membrane potential disruption, an increased Bax/Bcl-2 ratio, cytochrome c release, activation of caspase-9 and -3, and PARP-1 cleavage. Additionally, WTE effectively suppressed cell migration and colony formation. To elucidate the intricate molecular mechanisms driving these phenotypic outcomes, major bioactive constituents were identified by HPLC and subsequently analyzed using network pharmacology. Network pharmacology analysis suggested potential multi-target interactions involving regulators such as EGFR, NFKB1, and NFE2L2. However, further experimental validation is needed. Overall, these findings highlight that the combination of WTV and TE represents a promising botanical preparation for further CRC research.
No takes yet. Share an insight, caveat, or question.
Cheepchirasuk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: